STAA · Staar Surgical Co
Market Cap
$1.18B
Shares
50.14M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$239.44M
-23.7%
FY2025
Net Income
-$80.45M
-298.1%
FY2025
Gross Margin
76.19%
-0.1pp
FY2025
Operating Margin
-38.3%
-34.3pp
FY2025
Diluted EPS
-$1.62
-295.1%
FY2025
Operating Cash Flow
-$34.23M
-317.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $339.59M | $239.44M | $313.9MG | $322.42MG | $239.44M | $230.47M | $163.46M | $150.19M | $123.95M | $90.61M | $82.43M | $77.12M | $74.99M | $72.22M | $63.78M | $62.77M | $54.96M | $51.06M | |
| $79.39M | $57.02M | $74.32M | $69.76M | $61.01M | $51.84M | $45.1M | $38.23M | $32.44M | $26.33M | $24.06M | $24.4M | $26.16M | $21.91M | $19.49M | $20.4M | $19.88M | $19.74M | |
| $260.2M | $182.42M | $239.58M | $252.65M | $223.38M | $178.64M | $118.36M | $111.95M | $91.51M | $64.28M | $58.37M | $52.72M | $48.82M | $50.31M | $44.29M | $42.37M | $35.08M | $31.32M | |
| — | 76.19% | 76.32% | 78.36% | 93.29% | 77.51% | 72.41% | 74.54% | 73.83% | 70.94% | 70.81% | 68.36% | 65.11% | 69.67% | 69.44% | 67.5% | 63.82% | 61.35% | |
| $38.32M | $40.06M | $45.32M | $40.48M | $35.98M | $33.86M | $31.92M | $25.3M | $22.03M | $20.04M | $20.67M | $14.76M | $12.36M | $6.71M | $6.44M | $5.87M | $5.72M | $5.89M | |
| $100.75M | $102.53M | $116.98M | $111.76M | $88.86M | $67.29M | $45.76M | $45.49M | $38.6M | $28.4M | $28.69M | $23.7M | $25.88M | $23.89M | $21.28M | $17.73M | $17.18M | $15.3M | |
| $80.12M | $85.78M | $89.9M | $72.32M | $54.74M | $44.14M | $33.91M | $29.31M | $24.29M | $19.47M | $21.67M | $19.6M | $18.29M | $16.77M | $15.15M | $14.93M | $14.78M | $15.01M | |
| $246.47M | $274.13M | $252.19M | $224.55M | $179.58M | $145.3M | $111.59M | $100.1M | $84.92M | $67.91M | $71.02M | — | — | — | — | — | — | — | |
| — | — | — | $13K | $28K | $34K | $35K | $34K | $34K | $221K | $228K | $205K | $382K | $440K | $652K | $797K | $816K | $1.4M | |
| — | — | — | — | — | — | — | — | — | — | — | — | $321K | $2.24M | $2.64M | $1.06M | — | — | |
| $13.73M | -$91.71M | -$12.61M | $28.1M | $43.8M | $33.34M | $6.77M | $11.85M | $6.6M | -$3.63M | -$12.66M | -$5.34M | -$8.03M | $700K | -$1.22M | $2.78M | -$2.6M | -$4.88M | |
| — | -38.3% | -4.02% | 8.71% | 18.29% | 14.47% | 4.14% | 7.89% | 5.32% | -4.01% | -15.35% | -6.92% | -10.7% | 0.97% | -1.91% | 4.43% | -4.73% | -9.56% | |
| — | — | — | — | — | — | — | — | — | $112K | $112K | $78K | $154K | $170K | $291K | $523K | $896K | $1.32M | |
| — | — | — | — | — | — | — | — | — | — | $3000 | $50K | $51K | $59K | $59K | $32K | $43K | $67K | |
| $3.65M | $9.45M | $3.56M | $5.6M | $1.75M | -$2.04M | $1.5M | $1.17M | $44K | $1.34M | $211K | -$268K | -$618K | $414K | $701K | -$79K | -$1.08M | -$869K | |
| $17.38M | -$82.26M | -$9.05M | $33.7M | $45.55M | $31.3M | $8.27M | $13.03M | $6.64M | -$2.3M | -$12.44M | -$5.61M | -$8.65M | $1.11M | -$519K | $2.7M | -$3.68M | -$5.75M | |
| $13.54M | -$1.82M | $11.16M | $12.35M | $5.89M | $3.79M | $2.35M | -$1.02M | $1.67M | -$157K | -$315K | $928K | -$253K | $716K | $1.24M | $1.36M | $432K | $1.15M | |
| $3.84M | -$80.45M | -$20.21M | $21.35M | $39.67M | $27.51M | $5.91M | $14.05M | $4.97M | -$2.14M | -$12.13M | -$6.53M | -$8.39M | $398K | -$1.76M | $1.35M | $53K | -$6.2M | |
| — | -33.6% | -6.44% | — | 16.57% | 11.94% | 3.62% | 9.35% | 4.01% | -2.36% | -14.71% | -8.47% | -11.19% | 0.55% | -2.76% | 2.15% | 0.1% | -12.14% | |
| $2.52M | -$79.93M | -$23.13M | $17.08M | $43.87M | $29.01M | $3.42M | $12.32M | $4.8M | -$2.24M | -$11.6M | -$7.04M | -$9.74M | -$900K | -$2.59M | $1.65M | -$1.1M | -$5.76M | |
| USD/shares | $0.08 | -$1.62 | -$0.41 | $0.44 | $0.83 | $0.58 | $0.13 | $0.32 | $0.12 | -$0.05 | -$0.30 | -$0.17 | -$0.22 | $0.01 | -$0.05 | $0.04 | $0.00 | -$0.19 |
| USD/shares | $0.08 | -$1.62 | -$0.41 | $0.43 | $0.80 | $0.56 | $0.12 | $0.30 | $0.11 | -$0.05 | -$0.30 | -$0.17 | -$0.22 | $0.01 | -$0.05 | $0.04 | $0.00 | -$0.19 |
| shares | — | 49.57M | 49.13M | 48.52M | 47.99M | 47.21M | 45.61M | 44.49M | 42.59M | 41M | 40.33M | 39.26M | 38.09M | 36.71M | 36.25M | 35.43M | 34.83K | 32.5M |
| shares | — | 49.57M | 49.13M | 49.43M | 49.38M | 49.46M | 47.95M | 46.9M | 45.26M | 41M | 40.33M | 39.26M | 38.09M | 38.61M | 36.25M | 36.88M | 34.83K | 32.5M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.65×
EV/EBIT
—
Peer median 34.53×
P/E (TTM)
294.69×
Peer median 28.49×
Peer medians compare against the 25 similar-size Medical Instruments & Supplies companies (of 45 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Implantable Collamer Lenses | $312,543,000 | $319,427,000 | $269,712,000 | $212,905,000 | $141,407,000 | $129,322,000 | $101,082,000 | $68,325,000 |
| Intraocular Lenses | — | — | — | — | $13,574,000 | $15,689,000 | $16,193,000 | $17,258,000 |
| Other Surgical Products | — | — | — | — | $8,479,000 | $5,174,000 | $6,679,000 | $5,028,000 |
Key facts
CIK
718937
CUSIP
852312305
13F (30d)
153 filings
153 filers
Visit website
Investor relations